Together, the upregulated transcription of GABRA1, GABRA6, GAD2, GLRA2, and GLRA3 and downregulation of SLC6A13 strongly suggest increased inhibition in the ALS-Ox frontal and motor cortex. Here, GLRA2 is linked to amyotrophic lateral sclerosis.